| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 04/21/2004 | CN1491227A Triazoloquinazoline and pyrazolotriazolopyrimidine derivatives, medicinal compositions, adenosine A3 receptor affinity agents, ocular tension lowering agents, preparations for preventing and treating |
| 04/21/2004 | CN1491225A Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as active ingredient |
| 04/21/2004 | CN1491222A Piperidinee derivatives as neurokinin/antagonists |
| 04/21/2004 | CN1491208A Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical |
| 04/21/2004 | CN1491206A Malic acid addition salts of terbinafine |
| 04/21/2004 | CN1491107A Use of compound for treating tinnitus |
| 04/21/2004 | CN1491102A Ophthalmic compositions |
| 04/21/2004 | CN1490026A Bear gall lozenge and preparing method thereof |
| 04/21/2004 | CN1490025A Bear gall granular formulation and preparing method thereof |
| 04/21/2004 | CN1490011A Methanesulfonic pazuthacin injection and its preparing process against infection |
| 04/21/2004 | CN1146564C Antibiotic sultam and sultone drived oxazolidiones |
| 04/21/2004 | CN1146455C 1,2,4,5-tetrahydro-benzo[d] azepine compound |
| 04/21/2004 | CN1146441C Composition of containing lympha toxin beta receptor |
| 04/21/2004 | CN1146423C Prostaglandin product |
| 04/21/2004 | CN1146416C Use of H+, K+-ATPase inhibitor in treatment of nasal polyps |
| 04/21/2004 | CN1146404C Opthalmic solution comprising glycogen |
| 04/20/2004 | US6723855 Chlorinating 5-methylisoxazole-4-carboxylic acid by reacting with chlorinating agent to form 5-methylisoxazole-4-carboxylic acid chloride, reacting with 4-trifluoromethylaniline in presence of alkali metal or alkaline earth metal bicarbonate |
| 04/20/2004 | US6723755 Method of treating rosacea |
| 04/20/2004 | US6723744 Indole carboxylic acids as thyroid receptor ligands |
| 04/20/2004 | US6723741 Benzimidazoles and benzothiazoles and uses thereof |
| 04/20/2004 | US6723736 For therapy inflammation, inflammatory diseases, immunologic diseases and other diseases mediated by tumor necrosis factor-alpha (tnf-alpha) and/or interleukin 6 or 10 and/or enzyme cyclooxygenase-2 (cox-2) |
| 04/20/2004 | US6723730 Capsaicin receptor ligands |
| 04/20/2004 | US6723719 Dysmenorrhoea, benign prostatic hyperplasia (bph), bladder outlet obstruction, incontinence, agina, congestive heart failure, atherosclerosis; hypotensive and antiallergen agents |
| 04/20/2004 | US6723350 Powder of one or more antimicrobial metals formed with atomic disorder; coating becomes antimicrobial and anti-inflammatory when wet. |
| 04/20/2004 | US6723327 Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae |
| 04/20/2004 | CA2087420C Ophthalmic pharmaceutical composition containing n-acetyl-cisteine and polyvinylalcohol |
| 04/15/2004 | WO2004031180A1 Quinazolin-4-one derivatives |
| 04/15/2004 | WO2004031177A1 2-aminobenzimidazole derivative |
| 04/15/2004 | WO2004030702A1 Drug for auditory dysfunction |
| 04/15/2004 | WO2004030693A1 Enzymatic treatment of retinitis pigmentosa and relevant pharmaceutical composition in form of a kit |
| 04/15/2004 | WO2004030691A1 Sustained release preparation containing nk4 |
| 04/15/2004 | WO2004030666A1 Use of propionyl l-carnitine for the preparation of a medicament for the treatment of glaucoma |
| 04/15/2004 | WO2004014859A3 Process for preparing quinolin antibiotic intermediates |
| 04/15/2004 | WO2004014391B1 Use of carboxamides for the treatment of tinnitus |
| 04/15/2004 | WO2004006850A3 3, 10, AND 12a SUBSTITUTED TETRACYCLINE COMPOUNDS |
| 04/15/2004 | WO2004005309A3 Novel nonsteroidal anti-inflammatory substances, compositions and methods for their use |
| 04/15/2004 | WO2003099845A3 Fas peptide mimetics and uses thereof |
| 04/15/2004 | WO2003091266A3 Protein stabilisation using chaperone proteins |
| 04/15/2004 | WO2003082893A3 Theraputic methods and uses of sapogenins and their derivatives |
| 04/15/2004 | WO2003030913A3 Use of dendrimers in an ophthalmic composition |
| 04/15/2004 | WO2003028527A8 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 04/15/2004 | WO2002061052A8 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods |
| 04/15/2004 | WO2002009690A8 Pharmaceutical composition comprising a photochemotherapeutic agent and a mucoadhesive agent |
| 04/15/2004 | US20040073037 Anticholesterol agents; cardiovascular disorders; antiinflammatory agents; peroxisome proliferator activator receptor antagonist |
| 04/15/2004 | US20040073026 Cyclic protein tyrosine kinase inhibitors |
| 04/15/2004 | US20040073024 Phosphorus-containing compounds and uses thereof |
| 04/15/2004 | US20040072888 Administering pyrazoloanthrone compound |
| 04/15/2004 | US20040072883 Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 04/15/2004 | US20040072878 2,3-Diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage |
| 04/15/2004 | US20040072867 Antiemetics, antidepressants, anxiolytic agents, antitussive agents |
| 04/15/2004 | US20040072862 Compositions for treating ischemia-related neuronal damage |
| 04/15/2004 | US20040072846 Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives |
| 04/15/2004 | US20040072842 Difluorothioacetamides of oxazolidinones with a glycoloylpiperazine substituent |
| 04/15/2004 | US20040072841 Topical administration of oxazolidinones for transdermal delivery |
| 04/15/2004 | US20040072833 Antidepressants; anxiolytic agents; eating disorders; antiulcer agents; drug abuse; Alzheimer's disease |
| 04/15/2004 | US20040072832 Anticancer agents; antiinflammatory agents |
| 04/15/2004 | US20040072821 N-substituted glycine derivatives |
| 04/15/2004 | US20040072818 Antiinflammatory agents; autoimmune disease; anticancer agents |
| 04/15/2004 | US20040072816 Dysmenorrhea; congestive heart failure; liver disorders; vision defects |
| 04/15/2004 | US20040072762 Diazocine derivatives and their use as tryptase inhibitors |
| 04/15/2004 | US20040072238 Integrin binding polipeptide for diagnosis, prevention and treatment of renal failure, thrombosis, osteoporosis, cancers and diabetes |
| 04/15/2004 | US20040072174 Calpain protease 12 |
| 04/15/2004 | US20040071778 Gel administered as drops or ointment with free-flowing vehicle and benzyllauryldimethylammonium chloride preservative |
| 04/15/2004 | US20040071731 Chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
| 04/15/2004 | US20040071711 Imaging, diagnosis and treatment of disease |
| 04/15/2004 | US20040071697 Reducing epithelial toxicity during cancer therapy |
| 04/15/2004 | CA2504015A1 Use of propionyl l-carnitine for the preparation of a medicament for the treatment of glaucoma |
| 04/15/2004 | CA2503674A1 Quinazolin-4-one derivatives |
| 04/15/2004 | CA2500278A1 Pharmaceutical preparation for hearing impairment |
| 04/15/2004 | CA2500068A1 Enzymatic treatment of retinitis pigmentosa and relevant pharmaceutical composition in form of a kit |
| 04/14/2004 | EP1408117A1 Glycoprotein and process for producing the same |
| 04/14/2004 | EP1407795A2 Nasal delivery devices |
| 04/14/2004 | EP1407770A1 Tgf-beta superfamily production/secretion promoter |
| 04/14/2004 | EP1407768A2 The potassium channel opener retigabine for the treatment of diseases |
| 04/14/2004 | EP1406922A2 Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs |
| 04/14/2004 | EP1406910A1 Novel bisphosphonate derivatives, their preparation methods and uses |
| 04/14/2004 | EP1406901A1 Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease |
| 04/14/2004 | EP1406876A1 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors |
| 04/14/2004 | EP1406875A1 N-heterocyclic inhibitors of tnf-alpha expression |
| 04/14/2004 | EP1406872A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 04/14/2004 | EP1406859A1 Substituted 4-aminocyclohexanol derivatives |
| 04/14/2004 | EP1406858A1 Substituted 4-aminocyclohexanols |
| 04/14/2004 | EP1406857A1 Substituted 1-aryl-but-3-enylamine and 1-ary-but-2-enylamine compounds |
| 04/14/2004 | EP1406854A1 Process and intermediates to prepare latanoprost |
| 04/14/2004 | EP1406700A1 Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent |
| 04/14/2004 | EP1406667A2 METHODS FOR INCREASING i IN VIVO /i EFFICACY OF OLIGONUCLEOTIDES AND INHIBITING INFLAMMATION IN MAMMALS |
| 04/14/2004 | EP1406656A2 METHODS OF ADMINISTERING ANTI-TNF$g(a) ANTIBODIES |
| 04/14/2004 | EP1406650A1 Use of poly-glu, tyr and t cells treated therewith for neuroprotection therapy |
| 04/14/2004 | EP1406647A1 Use of antimicrobial peptides as preservatives in ophthalmic preparations including solutions emulsions and suspensions |
| 04/14/2004 | EP1406644A2 Modified proteins, designer toxins, and methods of making thereof |
| 04/14/2004 | EP1406637A2 Pharmaceutical compositions with wound healing or anti-complementary activity comprising a dextran derivative |
| 04/14/2004 | EP1406626A2 Sulphonyl aryl hydroxamates and their use as mmp inhibitors |
| 04/14/2004 | EP1406622A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 04/14/2004 | EP1406618A2 Use of nk-1 receptor antagonists with pyridinic structure for the treatment of brain, spinal or nerve injury |
| 04/14/2004 | EP1406616A1 Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same |
| 04/14/2004 | EP1406611A2 Method for treating fibrotic diseases or other indications |
| 04/14/2004 | EP1406609A2 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 04/14/2004 | EP1406602A2 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors |
| 04/14/2004 | EP1406600A1 Compositions and methods of administering tubulin binding agents for the treatment of ocular diseases |
| 04/14/2004 | EP1375465A9 Cyclooctanone derivative and cyclodecanone derivative, and use thereof |